Bio-Rad Laboratories BIO Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
Based on trailing twelve months.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's return on assets?
- Bio-Rad Laboratories (BIO) reported return on assets of 1.7% in Q1 2026.
- How has Bio-Rad Laboratories's return on assets changed year-over-year?
- Bio-Rad Laboratories's return on assets increased by 108.9% year-over-year, from -19.6% to 1.7%.
- What is the long-term trend for Bio-Rad Laboratories's return on assets?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's return on assets has grown at a -26.8% compound annual growth rate (CAGR), from 36.3% to 7.6%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.